EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report

Dan J Stein iD, Alan E Kazdin, David S Baldwin iD, Meredith G Harris, Irving Hwang, Julia R Pozuelo, Nancy A Sampson, Peter Woodruff, Maria Carmen Viana, Sergio Aguilar-Gaxiola, Ali Al-Hamzawi, Jordi Alonso und 20 weitere

Human Psychopharmacology: Clinical and Experimental · 2026

DOI: 10.1002/hup.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2026. Verfasst von Dan J Stein und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Neuroscience Institute, SAMRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Afr…. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Benzodiazepines, Developing Countries, Anxiety Disorders. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, FIC NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anxiolytic medications, particularly benzodiazepines, are widely prescribed, giving impetus to long‐standing debates about how often these agents should be employed in clinical practice. There are, however, few cross‐country studies of the pharmacoepidemiology of these agents. We report on the frequency of anxiolytic medication use, reasons for use, and perceived effectiveness of use in general population surveys across 20 countries.

Methods

Face‐to‐face interviews with community samples totaling n = 49,919 respondents in the World Health Organization World Mental Health (WMH) Surveys asked about anxiolytic medication use anytime in the prior 12 months in conjunction with validated fully structured diagnostic interviews. Treatment questions were administered independently of diagnoses to all respondents.

Results

A weighted 5.6% ( n = 4079) of respondents reported anxiolytic medication use within the past 12 months; the vast majority comprised benzodiazepine use, and use was highest amongst respondents with a subthreshold major depressive episode (MDE) (25.2%) and a 12‐month MDE (19.8%). Rates were significantly higher in high‐income countries (HICs) than low‐ and middle‐income countries (LMICs) (8.5% vs. 2.2%, χ 2 1 = 559.6, p < 0.001). Short‐acting benzodiazepines and z‐drugs were most commonly used for sleep (66.5% and 85.5%), while intermediate‐acting benzodiazepines and long‐acting benzodiazepines were most commonly used either for sleep (37.9% and 30.1%) or anxiety (33.3% and 32.0%). Across all conditions, anxiolytic medications were reported as very effective by 55.7% of users and somewhat effective by an additional 32.2% of users, with similar proportions in HICs and LMICs. Negative predictors of high perceived effectiveness were a 12‐month MDE and taking anxiolytic medication for comorbid anxiety and depression.

Conclusion

These data do not definitely answer the question of how often benzodiazepines should be prescribed in clinical practice, but they usefully inform discussions of how to optimize their use. It is noteworthy that anxiolytic medications, particularly benzodiazepines, are largely prescribed for anxiety and sleep, and that they are widely perceived to be either very or somewhat effective by users. However, more targeted prescription of these agents may be necessary; in particular antidepressant intervention should be prioritized in the pharmacotherapy of major depressive disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsBenzodiazepinesDeveloping CountriesAnxiety DisordersHumansMaleFemaleAdultMiddle AgedDeveloped CountriesYoung AdultHealth SurveysAdolescentAgedMajor Depressive DisorderGlobal Health

Stichwörter der Autor:innen

anxiolytic medicationsperceived effectivenessreasons for use

Substanzen

Anti-Anxiety AgentsBenzodiazepines

Autor:innen und Institutionen

  • Department of Psychiatry & Neuroscience Institute, SAMRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa.
  • Department of Psychology, Yale University, New Haven, Connecticut, USA.
  • Faculty of Medicine, University of Southampton, Southampton, UK.
  • School of Public Health, The University of Queensland, Herston, Australia.
  • Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Queensland, Australia.
  • Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Dan J Stein, David S Baldwin, Corina Benjet, Giovanni de Girolamo, Elie G Karam, Ronald C Kessler

Förderung

  • NIDA NIH HHS
  • FIC NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Stein, D. J., Kazdin, A. E., Baldwin, D. S., Harris, M. G., Hwang, I., Pozuelo, J. R., Sampson, N. A., Woodruff, P., Viana, M. C., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L. H., Benjet, C., Bruffaerts, R., Caldas-de-Almeida, J. M., Chardoul, S., de Girolamo, G., Gureje, O., …, & WHO World Mental Health Survey collaborators (2026). Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.70031

Vancouver

Stein DJ, Kazdin AE, Baldwin DS, Harris MG, Hwang I, Pozuelo JR, et al. Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report. Human Psychopharmacology: Clinical and Experimental. 2026. doi:10.1002/hup.70031

BibTeX
@article{Stein2026,
  author = {Stein, Dan J and Kazdin, Alan E and Baldwin, David S and Harris, Meredith G and Hwang, Irving and Pozuelo, Julia R and Sampson, Nancy A and Woodruff, Peter and Viana, Maria Carmen and Aguilar-Gaxiola, Sergio and Al-Hamzawi, Ali and Alonso, Jordi and Andrade, Laura Helena and Benjet, Corina and Bruffaerts, Ronny and Caldas-de-Almeida, José-Miguel and Chardoul, Stephanie and de Girolamo, Giovanni and Gureje, Oye and Haro, Josep M and Karam, Elie G and Karam, Aimee and Kovess-Masfety, Viviane and Navarro-Mateu, Fernando and Nishi, Daisuke and Posada-Villa, José and Roest, Annelieke and Stagnaro, Juan Carlos and Vladescu, Cristian and Vigo, Daniel V and Kessler, Ronald C and WHO World Mental Health Survey collaborators, WHO World Mental Health Survey collaborators},
  title = {Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2026},
  doi = {10.1002/hup.70031}
}
Kostenlos starten →